Key result
Acute afterload reduction with IV hydralazine in severe aortic regurgitation identified a subset of patients with improved LV response (regurgitant fraction decreased from 50% to 36%, P<0.03).
Why the study?
Does acute afterload reduction with IV hydralazine improve LV volumetric response in asymptomatic patients with severe aortic regurgitation?
Does acute afterload reduction with IV hydralazine improve LV volumetric response in asymptomatic patients with severe aortic regurgitation?
Beat-to-beat MRI analysis during acute vasodilation can identify severe AR patients with advanced cardiac adaptation based on the absence of improved LV volumetric response.
This study was designed to assess the effects of afterload reduction in asymptomatic patients with severe aortic regurgitation (AR) and maintained LV function by cine-MRI. We studied 13 patients at baseline and after 0.2 mg/kg Hydralazine (I.V.). Patients were stratified according to the volumetric LV response to acute afterload reduction: Group I comprised patients with improved LV response; Group II comprised patients with unchanged or deteriorated LV response. Baseline LV function and severity of AR were not significantly different between groups. However, regurgitant fraction decreased (50 +/- 12 vs. 36 +/- 9%; P < 0.03) and cardiac output increased (4.9 +/- 1.4 vs. 7.1 +/- 1.6l/minute; P < 0,001) in Group I and remained unchanged in Group II (54 +/- 10 vs. 55 +/- 10%, P = n.s. and 5.5 +/- 1.4 vs. 6.6 +/- 0.9l/minute; P = n.s.) during maximal vasodilation. Beat-to-beat analysis revealed a decrease of left ventricular endsystolic volume index in group I (48 +/- 13 vs. 37 +/- 9 ml/beat; P < 0.05) and no change in group II (61 +/- 20 vs. 62 +/- 20 ml/beat; P = n.s.). In the natural history of chronic AR, the absence of improved LV performance during acute vasodilation using beat-to-beat analysis by MRI may identify patients with more advanced cardiac adaptation to chronic volume overload.
No takes yet. Share an insight, caveat, or question.
Hoffmann et al. (2001) studied Severe aortic regurgitation (n=13). Hydralazine (I.V.) vs. Baseline was evaluated on Volumetric LV response to acute afterload reduction. Acute afterload reduction with IV hydralazine in severe aortic regurgitation identified a subset of patients with improved LV response (regurgitant fraction decreased from 50% to 36%, P<0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: